Distillate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$49.2M |
| 2 |
Procter & Gamble
PG
|
+$43.1M |
| 3 |
Qualcomm
QCOM
|
+$35.9M |
| 4 |
Adobe
ADBE
|
+$35.2M |
| 5 |
Lowe's Companies
LOW
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$77.6M |
| 2 |
Abbott
ABT
|
+$62.5M |
| 3 |
Johnson & Johnson
JNJ
|
+$55.1M |
| 4 |
Automatic Data Processing
ADP
|
+$54.9M |
| 5 |
Salesforce
CRM
|
+$36.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.45% |
| 2 | Technology | 21.91% |
| 3 | Industrials | 14.73% |
| 4 | Consumer Discretionary | 13.62% |
| 5 | Consumer Staples | 8.72% |
Similar funds
Distillate Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Distillate Capital Partners held 128 positions worth $2.04B, up 2% from $2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Distillate Capital Partners deployed $178M of net new capital in Q4 2024, opening 64 new positions and adding to 15 existing holdings. Its largest new stake was T-Mobile US: 216,512 shares worth $47.8M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $55.1M trimmed.
- Distillate Capital Partners's largest Q4 2024 buy was T-Mobile US: 216,512 shares worth $47.8M.
- Distillate Capital Partners added most to UnitedHealth in Q4 2024, an estimated $13.4M increase.
- Distillate Capital Partners's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $55.1M.
- Distillate Capital Partners fully exited Amgen in Q4 2024, selling an estimated $77.6M.
- Distillate Capital Partners's ten largest holdings make up 22% of its $2.04B portfolio in Q4 2024.
- Distillate Capital Partners opened 64 new positions and closed 10 in Q4 2024.
- Distillate Capital Partners's portfolio value rose 2% quarter-over-quarter to $2.04B.
Based on Distillate Capital Partners's 13F filing for Q4 2024, filed 13 Feb 2025.